1. Investigating the association between allergic diseases and COVID-19 in 400 Iranian patients.
- Author
-
Darabi A, Dehghanfard M, Jozan S, Tahmasebi R, Movahed A, Zamani M, and Farrokhi S
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, COVID-19 diagnosis, COVID-19 Testing, Comorbidity, Female, Humans, Hypersensitivity diagnosis, Iran epidemiology, Male, Middle Aged, Risk Factors, Severity of Illness Index, Young Adult, COVID-19 epidemiology, Hypersensitivity epidemiology
- Abstract
Introduction: Allergic diseases could play a role of a predisposing factor for coronavirus disease 2019 (COVID-19). The aim of this study was to investigate allergic comorbidity and its association in COVID-19 patients., Methods: Demographic data, clinical manifestations, laboratory reports, and radiologic findings, together with underlying comorbidity of patients, were studies. Allergic diseases were identified by using the standard GA
2 LEN questionnaire. The severity of COVID-19 was assessed by a visual analog scale (VAS) and an intensive care unit (ICU) report., Results: Out of 400 COVID-19 patients admitted in the hospital, 158 (39.5%) presented with different allergic diseases, and a reverse association was observed between having allergic comorbidity and severity of COVID-19 infection (P = 0.005, relative risk = 0.96; 95% Confidence Interval (95% CI): 0.77-1.19). The respective frequency of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS), atopic dermatitis, chronic urticaria, and food or drug allergy was 7.3%, 16%, 1.8%, 5%, 10% and 13.3%. Significantly, only AR was reversely associated with the severity of COVID-19 (P = 0.02, relative risk = 0.45; 95% CI: 0.77-1.19). Additionally, 43% of the patients presented hypoxemia, and 93.5% had chest CT scan involvement. Interestingly, patients with allergic diseases had significantly lower hypoxemia and chest CT involvement as compared with non-allergic patients (P = 0.002 and 0.003, respectively)., Conclusion: The results of this study established that allergic diseases were not determined to be a predisposing factor for the severe acute respiratory syndrome (SARS) due to coronavirus 2 (SARS-CoV-2) infection. Significantly, AR patients developed mild clinical manifestations of COVID-19 and admitted to ICU as compared to non-AR patients., Competing Interests: There were no conflicts of interest in this study.- Published
- 2021
- Full Text
- View/download PDF